Live Earnings Conference Call: Synopsys will host a live Q2 2025 earnings call on May 28, 2025 at 5:00PM ET. Get details.

Synopsys (SNPS) Financials

$511.79 +12.94 (+2.59%)

Closing price 05/27/2025 04:00 PM Eastern

Extended Trading

$511.48 -0.31 (-0.06%)

As of 04:19 AM Eastern

Compare

Annual Income Statements for Synopsys

This table shows Synopsys' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015
Net Income / (Loss) Attributable to Common Shareholders	2,263	1,230	985	758	664	532	433	137	267	226
Consolidated Net Income / (Loss)	2,236	1,218	978	756	663	532	433	137	267	226
Net Income / (Loss) Continuing Operations	1,414	1,215	964	756	663	532	433	137	267	226
Total Pre-Tax Income	1,514	1,305	1,103	806	638	546	364	383	330	282
Total Operating Income	1,356	1,273	1,149	735	620	520	360	348	317	266
Total Gross Profit	4,882	4,287	3,718	3,342	2,891	2,608	2,385	2,071	1,880	1,723
Total Revenue	6,127	5,318	4,616	4,204	3,685	3,361	3,121	2,725	2,423	2,242
Operating Revenue	6,127	5,318	4,616	4,204	3,685	3,361	3,121	2,725	2,423	2,242
Total Cost of Revenue	1,245	1,031	898	862	795	753	736	654	543	519
Operating Cost of Revenue	1,245	1,031	898	862	795	753	736	654	543	519
Total Operating Expenses	3,526	3,014	2,569	2,608	2,270	2,088	2,025	1,723	1,562	1,457
Selling, General & Admin Expense	568	377	314	323	285	229	263	197	166	165
Marketing Expense	859	725	643	712	632	633	623	549	502	474
Research & Development Expense	2,082	1,850	1,590	1,505	1,279	1,137	1,085	909	857	776
Amortization Expense	16	9.30	12	-	-	-	42	-	-	-
Restructuring Charge	0.00	53	11	33	36	47	13	37	9.63	15
Total Other Income / (Expense), net	158	32	-45	71	18	25	3.32	36	12	15
Other Income / (Expense), net	158	32	-45	71	18	25	3.32	36	12	15
Income Tax Expense	100	90	139	49	-25	13	-69	247	63	56
Net Income / (Loss) Discontinued Operations	822	2.84	14	-	-	-	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	-28	-12	-6.16	-1.16	-0.90	0.00	0.00	-	-	-
Basic Earnings per Share	$14.78	$8.08	$6.44	$4.96	$4.40	$3.55	$2.90	$0.91	$1.76	$1.46
Weighted Average Basic Shares Outstanding	153.14M	152.15M	153.00M	152.70M	151.14M	149.87M	149.04M	150.46M	152.02M	154.96M
Diluted Earnings per Share	$14.51	$7.92	$6.29	$4.81	$4.27	$3.45	$2.82	$0.88	$1.73	$1.43
Weighted Average Diluted Shares Outstanding	155.94M	155.20M	156.49M	157.34M	155.71M	154.19M	153.39M	154.87M	154.72M	158.07M
Weighted Average Basic & Diluted Shares Outstanding	154.58M	151.99M	152.42M	153.44M	153.03M	150.53M	149.52M	148.71M	151.60M	154.70M

This table shows Synopsys' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Income / (Loss) Attributable to Common Shareholders	296	1,114	408	292	449	349	336	273	272	154	223
Consolidated Net Income / (Loss)	297	1,096	405	289	446	346	333	270	269	152	220
Net Income / (Loss) Continuing Operations	297	249	423	296	435	5.80	668	273	269	137	220
Total Pre-Tax Income	291	315	392	342	457	404	326	297	279	200	236
Total Operating Income	252	304	360	332	353	425	300	292	256	204	234
Total Gross Profit	1,185	1,173	1,235	1,154	1,232	1,102	1,094	1,015	1,077	701	977
Total Revenue	1,455	1,498	1,526	1,455	1,511	1,340	1,354	1,263	1,361	818	1,248
Operating Revenue	1,455	1,498	1,526	1,455	1,511	1,340	1,354	1,263	1,361	818	1,248
Total Cost of Revenue	270	325	291	300	279	238	260	248	284	117	271
Operating Cost of Revenue	270	325	291	300	279	238	260	248	284	117	271
Total Operating Expenses	934	869	875	822	879	677	794	722	821	497	743
Selling, General & Admin Expense	167	165	150	115	131	95	100	85	97	67	91
Marketing Expense	209	175	211	210	219	148	186	181	211	71	199
Research & Development Expense	553	528	509	493	526	440	484	460	465	371	445
Amortization Expense	4.00	-	-	-	3.53	-	2.01	-	-	-	-
Total Other Income / (Expense), net	39	11	32	9.46	105	-21	25	4.21	23	-3.98	2.43
Other Income / (Expense), net	39	11	32	9.46	105	-21	25	4.21	23	-3.98	2.43
Income Tax Expense	-6.29	66	-31	45	23	63	-6.95	24	11	63	17
Net Income / (Loss) Discontinued Operations	0.00	-	-18	-7.00	12	-	1.09	-2.69	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	1.73	-18	-3.16	-3.02	-2.91	-2.70	-3.20	-2.96	-2.91	-1.94	-2.98
Basic Earnings per Share	$1.91	$7.26	$2.66	$1.91	$2.95	$2.30	$2.21	$1.79	$1.78	$1.00	$1.46
Weighted Average Basic Shares Outstanding	154.41M	153.14M	153.42M	152.97M	152.31M	152.15M	152.02M	152.19M	152.40M	153.00M	152.94M
Diluted Earnings per Share	$1.89	$7.13	$2.61	$1.88	$2.89	$2.24	$2.17	$1.76	$1.75	$0.98	$1.43
Weighted Average Diluted Shares Outstanding	156.19M	155.94M	156.13M	155.77M	155.33M	155.20M	154.95M	154.73M	155.08M	156.49M	155.81M
Weighted Average Basic & Diluted Shares Outstanding	154.62M	154.58M	153.61M	153.22M	152.54M	151.99M	304.17M	304.32M	152.30M	152.42M	152.91M

This table details how cash moves in and out of Synopsys' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015
Net Change in Cash & Equivalents	2,458	21	-15	197	507	2.74	-325	70	140	-150
Net Cash From Operating Activities	1,407	1,703	1,739	1,493	991	801	424	632	587	495
Net Cash From Continuing Operating Activities	1,407	1,703	1,739	1,493	991	801	424	632	587	495
Net Income / (Loss) Continuing Operations	2,236	1,218	978	756	663	532	433	137	267	226
Consolidated Net Income / (Loss)	2,236	1,218	978	756	663	532	433	137	267	226
Depreciation Expense	295	247	228	204	210	202	209	189	207	212
Amortization Expense	107	82	73	65	61	63	0.00	0.00	-	-
Non-Cash Adjustments To Reconcile Net Income	-116	694	555	466	357	162	142	112	99	88
Changes in Operating Assets and Liabilities, net	-1,115	-538	-96	1.60	-300	-158	-360	195	14	-30
Net Cash From Investing Activities	1,223	-482	-573	-549	-360	-236	-744	-189	-143	-560
Net Cash From Continuing Investing Activities	1,223	-482	-573	-549	-360	-236	-744	-189	-143	-560
Purchase of Property, Plant & Equipment	-123	-192	-139	-96	-159	-202	-102	-74	-71	-91
Acquisitions	-157	-298	-422	-296	-201	-37	-653	-259	-60	-340
Purchase of Investments	-138	-132	-104	-169	-2.76	-3.25	-3.56	-155	-170	-239
Divestitures	1,447	0.00	0.00	-	-	-	-	-	-	-
Sale and/or Maturity of Investments	195	139	94	13	2.15	6.36	13	296	158	109
Other Investing Activities, net	0.00	0.00	-1.20	-0.80	0.00	0.00	-	2.10	0.00	0.90
Net Cash From Financing Activities	-181	-1,197	-1,116	-749	-141	-562	5.14	-373	-307	-62
Net Cash From Continuing Financing Activities	-181	-1,197	-1,116	-749	-141	-562	5.14	-373	-307	-62
Repayment of Debt	-76	-2.73	-80	-32	-290	-525	-294	-383	-191	-327
Repurchase of Common Equity	0.00	-1,206	-1,100	-788	-242	-329	-400	-400	-400	-280
Issuance of Common Equity	232	253	238	211	197	156	124	126	125	110
Other Financing Activities, net	-338	-241	-174	-139	-82	-57	-46	-37	-27	-25
Effect of Exchange Rate Changes	8.80	-2.98	-65	2.37	17	-	-11	-	3.41	-23
Cash Interest Paid	0.81	1.00	1.26	3.37	5.14	12	15	7.10	3.71	2.71
Cash Income Taxes Paid	680	98	168	150	71	76	253	103	69	60

This table details how cash moves in and out of Synopsys' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Change in Cash & Equivalents	-241	2,039	348	390	-320	-247	142	389	-263	34	-190
Net Cash From Operating Activities	-67	563	455	477	-88	326	560	703	115	394	440
Net Cash From Continuing Operating Activities	-67	563	455	477	-88	326	560	703	115	394	440
Net Income / (Loss) Continuing Operations	297	1,096	405	289	446	346	333	270	269	152	220
Consolidated Net Income / (Loss)	297	1,096	405	289	446	346	333	270	269	152	220
Depreciation Expense	48	115	56	61	63	67	63	60	57	59	58
Amortization Expense	23	32	31	25	20	21	22	21	19	19	20
Non-Cash Adjustments To Reconcile Net Income	222	-684	209	204	155	179	179	170	166	150	154
Changes in Operating Assets and Liabilities, net	-658	4.52	-245	-103	-772	-287	-37	182	-396	15	-12
Net Cash From Investing Activities	-22	1,443	-54	-112	-54	-301	-54	-91	-36	-41	-345
Net Cash From Continuing Investing Activities	-22	1,443	-54	-112	-54	-301	-54	-91	-36	-41	-345
Purchase of Property, Plant & Equipment	-41	-4.39	-40	-38	-40	-53	-46	-48	-44	-36	-36
Acquisitions	0.00	-	-17	-72	-68	-246	-10	-41	0.00	-6.05	-307
Purchase of Investments	-41	-40	-32	-40	-26	-29	-34	-40	-29	-24	-28
Divestitures	24	-	-	-	0.00	-	-	-	-	-	-
Sale and/or Maturity of Investments	36	40	35	39	80	28	36	38	37	23	27
Other Investing Activities, net	-0.61	-	-	-	0.00	-	-	-	-	1.97	-1.51
Net Cash From Financing Activities	-142	30	-57	33	-187	-254	-351	-214	-377	-291	-266
Net Cash From Continuing Financing Activities	-142	30	-57	33	-187	-254	-351	-214	-377	-291	-266
Repayment of Debt	-1.29	-	-19	-7.81	-49	-	-1.31	-0.12	-1.29	-	-1.60
Payment of Dividends	-30	-	-	-	0.00	-	-	-	-	-	-
Issuance of Common Equity	14	89	28	106	9.48	88	32	110	22	77	41
Other Financing Activities, net	-125	-59	-66	-65	-147	-42	-82	-25	-92	-25	-48
Effect of Exchange Rate Changes	-9.68	3.34	3.04	-6.90	9.32	-18	-13	-7.97	36	-27	-18

This table presents Synopsys' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015
Total Assets	13,074	10,333	9,418	8,752	8,030	6,405	6,146	5,396	5,240	5,046
Total Current Assets	6,470	3,431	3,013	2,808	2,549	1,739	1,544	1,683	1,717	1,469
Cash & Equivalents	3,897	1,434	1,418	1,433	1,236	729	723	1,048	977	836
Short-Term Investments	154	152	148	148	0.00	-	-	-	141	129
Accounts Receivable	934	857	796	569	781	554	554	451	439	386
Inventories, net	362	326	212	229	192	142	122	62	-	-
Prepaid Expenses	1,123	548	439	430	308	290	68	73	105	71
Plant, Property, & Equipment, net	563	550	483	472	484	430	309	266	257	263
Total Noncurrent Assets	6,041	6,353	5,922	5,472	4,997	4,237	4,293	3,448	3,266	3,314
Goodwill	3,449	3,346	3,842	3,576	3,365	3,171	3,143	2,707	2,518	2,471
Intangible Assets	195	240	386	279	254	279	360	254	267	364
Noncurrent Deferred & Refundable Income Taxes	1,247	854	671	613	498	390	404	244	282	274
Other Noncurrent Operating Assets	1,150	1,005	1,023	1,004	880	396	385	243	200	205
Total Liabilities & Shareholders' Equity	13,074	10,333	9,418	8,752	8,030	6,405	6,146	5,396	5,240	5,046
Total Liabilities	4,050	4,149	3,859	3,453	3,118	2,316	2,661	2,117	2,045	1,912
Total Current Liabilities	2,650	2,985	2,774	2,413	2,140	1,752	2,102	1,614	1,715	1,578
Accounts Payable	1,164	1,060	809	741	624	506	578	500	401	386
Current Deferred Revenue	1,392	1,559	1,911	1,518	1,388	1,212	1,153	1,065	1,086	968
Other Current Liabilities	95	80	54	80	73	0.00	-	-	-	-
Total Noncurrent Liabilities	1,400	1,163	1,084	1,040	978	564	559	503	330	333
Long-Term Debt	16	18	21	25	101	120	126	134	0.00	-
Noncurrent Deferred Revenue	341	151	154	136	130	120	167	116	119	131
Other Noncurrent Operating Liabilities	1,044	961	909	878	747	324	266	252	211	202
Redeemable Noncontrolling Interest	30	31	39	0.00	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	8,993	6,153	5,521	5,299	4,912	4,089	3,485	3,280	3,195	3,134
Total Preferred & Common Equity	8,991	6,147	5,516	5,295	4,907	4,083	3,479	3,276	3,195	3,134
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	8,991	6,147	5,516	5,295	4,907	4,083	3,479	3,276	3,195	3,134
Common Stock	1,213	1,278	1,489	1,578	1,655	1,637	1,646	1,624	1,646	1,612
Retained Earnings	8,984	6,742	5,534	4,550	3,795	3,164	2,544	2,144	1,948	1,726
Treasury Stock	-1,026	-1,676	-1,273	-783	-489	-626	-598	-426	-294	-98
Accumulated Other Comprehensive Income / (Loss)	-180	-196	-234	-50	-54	-92	-113	-66	-105	-105
Noncontrolling Interest	2.50	5.95	4.80	3.81	4.96	5.86	5.86	4.10	0.00	-

This table presents Synopsys' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Total Assets	13,041	13,074	11,649	11,012	10,558	10,333	9,923	9,791	9,566	9,418	9,330
Total Current Assets	6,324	6,470	5,128	4,653	3,408	3,431	3,268	3,161	3,028	3,013	2,899
Cash & Equivalents	3,654	3,897	1,840	1,503	1,119	1,434	1,686	1,545	1,155	1,418	1,384
Short-Term Investments	155	154	154	157	154	152	148	151	147	148	148
Accounts Receivable	893	934	805	835	1,064	857	667	780	1,035	796	683
Inventories, net	415	362	386	378	383	326	283	256	221	212	220
Prepaid Expenses	1,206	1,123	915	760	688	548	484	429	470	439	465
Plant, Property, & Equipment, net	546	563	571	567	567	550	536	546	517	483	487
Total Noncurrent Assets	6,171	6,041	5,950	5,792	6,583	6,353	6,119	6,083	6,020	5,922	5,944
Goodwill	3,433	3,449	3,444	3,427	4,131	3,346	3,888	3,888	3,865	3,842	3,855
Intangible Assets	181	195	266	277	377	240	337	357	361	386	405
Noncurrent Deferred & Refundable Income Taxes	1,393	1,247	1,103	1,005	954	854	814	774	719	671	617
Other Noncurrent Operating Assets	1,164	1,150	1,136	1,083	1,120	1,005	1,081	1,064	1,075	1,023	1,067
Total Liabilities & Shareholders' Equity	13,041	13,074	11,649	11,012	10,558	10,333	9,923	9,791	9,566	9,418	9,330
Total Liabilities	3,736	4,050	3,903	3,823	3,852	4,149	3,923	3,918	3,887	3,859	3,678
Total Current Liabilities	2,359	2,650	2,535	2,508	2,645	2,985	2,730	2,749	2,725	2,774	2,546
Accounts Payable	939	1,164	757	636	699	1,060	905	702	664	809	736
Current Deferred Revenue	1,321	1,392	1,357	1,457	1,856	1,559	1,744	1,969	1,995	1,911	1,756
Other Current Liabilities	99	95	90	85	89	80	80	78	66	54	54
Total Noncurrent Liabilities	1,378	1,400	1,368	1,315	1,207	1,163	1,193	1,169	1,162	1,084	1,132
Long-Term Debt	14	16	16	17	17	18	18	20	21	21	22
Noncurrent Deferred Revenue	316	341	319	308	190	151	195	191	173	154	165
Other Noncurrent Operating Liabilities	1,047	1,044	1,034	990	1,000	961	980	958	969	909	945
Redeemable Noncontrolling Interest	0.00	30	31	31	31	31	36	36	36	39	44
Total Equity & Noncontrolling Interests	9,305	8,993	7,714	7,158	6,676	6,153	5,964	5,837	5,643	5,521	5,608
Total Preferred & Common Equity	9,305	8,991	7,709	7,153	6,671	6,147	5,959	5,832	5,637	5,516	5,604
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	9,305	8,991	7,709	7,153	6,671	6,147	5,959	5,832	5,637	5,516	5,604
Common Stock	1,129	1,213	1,194	1,184	1,185	1,278	1,259	1,332	1,294	1,489	1,417
Retained Earnings	9,279	8,984	7,884	7,478	7,189	6,742	6,390	6,075	5,806	5,534	5,378
Treasury Stock	-861	-1,026	-1,188	-1,322	-1,539	-1,676	-1,543	-1,429	-1,321	-1,273	-1,035
Accumulated Other Comprehensive Income / (Loss)	-242	-180	-180	-188	-163	-196	-147	-146	-142	-234	-155
Noncontrolling Interest	0.11	2.50	4.98	4.64	4.59	5.95	5.45	5.09	5.95	4.80	4.10

This table displays calculated financial ratios and metrics derived from Synopsys' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.22%	15.22%	9.79%	14.08%	9.66%	7.68%	14.54%	12.48%	8.04%	8.98%
EBITDA Growth	17.21%	16.36%	30.82%	18.10%	12.27%	41.41%	0.04%	6.70%	8.74%	6.12%
EBIT Growth	15.96%	18.31%	36.99%	26.22%	16.98%	50.05%	-5.10%	16.25%	17.02%	3.48%
NOPAT Growth	6.85%	18.10%	45.46%	7.02%	26.99%	18.46%	245.91%	-51.79%	20.21%	-9.73%
Net Income Growth	83.55%	24.50%	29.36%	14.00%	24.62%	23.09%	216.72%	-48.82%	18.10%	-12.81%
EPS Growth	83.21%	25.91%	30.77%	12.65%	23.77%	22.34%	220.45%	-49.13%	20.98%	-12.80%
Operating Cash Flow Growth	-17.39%	-2.05%	16.50%	50.57%	23.83%	88.62%	-32.90%	7.82%	18.47%	-10.13%
Free Cash Flow Firm Growth	-85.17%	59.40%	19.37%	100.05%	40.33%	156.38%	-1,461.98%	-90.99%	2,442.96%	60.63%
Invested Capital Growth	27.49%	-2.53%	5.14%	0.36%	8.77%	8.26%	36.03%	4.05%	-3.84%	10.66%
Revenue Q/Q Growth	-5.64%	1.05%	-6.75%	3.11%	4.97%	1.69%	3.26%	2.36%	1.96%	2.19%
EBITDA Q/Q Growth	-1.34%	14.12%	0.58%	0.99%	7.20%	11.95%	-5.61%	2.38%	3.62%	-0.20%
EBIT Q/Q Growth	-5.33%	17.24%	0.09%	0.94%	10.37%	17.03%	-11.59%	4.69%	8.86%	-2.16%
NOPAT Q/Q Growth	-8.90%	20.78%	-5.17%	-1.12%	7.27%	-16.37%	676.85%	-59.35%	9.16%	-3.21%
Net Income Q/Q Growth	50.39%	19.05%	-4.82%	0.61%	5.71%	-14.95%	644.33%	-58.53%	9.40%	-5.32%
EPS Q/Q Growth	50.83%	18.92%	-4.41%	0.00%	6.22%	-15.44%	605.00%	-58.49%	9.49%	-4.67%
Operating Cash Flow Q/Q Growth	20.23%	-3.81%	1.34%	12.72%	-1.89%	12.72%	-10.89%	5.88%	-0.80%	-3.97%
Free Cash Flow Firm Q/Q Growth	-62.08%	36.85%	24.58%	4.33%	7.98%	-6.09%	1.24%	-44.60%	124.86%	-108.82%
Invested Capital Q/Q Growth	-1.62%	-6.47%	-3.09%	2.31%	3.31%	3.04%	6.14%	-7.09%	-1.11%	6.56%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	79.68%	80.62%	80.54%	79.50%	78.44%	77.60%	76.42%	75.99%	77.59%	76.86%
EBITDA Margin	31.27%	30.74%	30.44%	25.54%	24.67%	24.10%	18.35%	21.01%	22.15%	22.01%
Operating Margin	22.13%	23.94%	24.89%	17.48%	16.83%	15.48%	11.54%	12.76%	13.10%	11.88%
EBIT Margin	24.71%	24.55%	23.91%	19.16%	17.32%	16.23%	11.65%	14.06%	13.60%	12.56%
Profit (Net Income) Margin	36.49%	22.91%	21.20%	17.99%	18.00%	15.84%	13.86%	5.01%	11.01%	10.08%
Tax Burden Percent	147.69%	93.31%	88.67%	93.90%	103.96%	97.59%	118.97%	35.65%	80.97%	80.23%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	6.59%	6.91%	12.63%	6.10%	-3.96%	2.41%	-18.97%	64.35%	19.03%	19.77%
Return on Invested Capital (ROIC)	28.45%	29.90%	25.63%	18.10%	17.66%	15.09%	15.29%	5.32%	11.04%	9.46%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.29%	28.18%	27.29%	12.97%	15.45%	9.25%	14.61%	3.93%	9.86%	8.01%
Return on Net Nonoperating Assets (RNNOA)	0.95%	-9.16%	-7.60%	-3.29%	-2.92%	-1.03%	-2.50%	-1.10%	-2.61%	-2.16%
Return on Equity (ROE)	29.40%	20.75%	18.02%	14.81%	14.74%	14.06%	12.79%	4.22%	8.43%	7.30%
Cash Return on Invested Capital (CROIC)	4.29%	32.47%	20.62%	17.74%	9.26%	7.16%	-15.24%	1.35%	14.95%	-0.66%
Operating Return on Assets (OROA)	12.94%	13.22%	12.15%	9.60%	8.84%	8.69%	6.30%	7.20%	6.41%	5.73%
Return on Assets (ROA)	19.10%	12.33%	10.77%	9.01%	9.19%	8.48%	7.49%	2.57%	5.19%	4.60%
Return on Common Equity (ROCE)	29.27%	20.60%	17.94%	14.80%	14.72%	14.04%	12.77%	4.22%	8.43%	7.30%
Return on Equity Simple (ROE_SIMPLE)	24.87%	19.82%	17.74%	14.28%	13.52%	13.04%	12.43%	4.17%	8.35%	7.21%
Net Operating Profit after Tax (NOPAT)	1,266	1,185	1,004	690	645	508	429	124	257	214
NOPAT Margin	20.67%	22.29%	21.74%	16.41%	17.49%	15.11%	13.73%	4.55%	10.61%	9.53%
Net Nonoperating Expense Percent (NNEP)	30.74%	1.72%	-1.66%	5.13%	2.21%	5.84%	0.68%	1.39%	1.18%	1.45%
Return On Investment Capital (ROIC_SIMPLE)	14.06%	19.21%	18.11%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	20.32%	19.38%	19.46%	20.50%	21.56%	22.40%	23.58%	24.01%	22.41%	23.14%
SG&A Expenses to Revenue	9.28%	7.08%	6.79%	7.68%	7.72%	6.82%	8.41%	7.22%	6.85%	7.36%
R&D to Revenue	33.98%	34.79%	34.44%	35.79%	34.71%	33.83%	34.76%	33.35%	35.36%	34.62%
Operating Expenses to Revenue	57.55%	56.67%	55.66%	62.02%	61.61%	62.12%	64.88%	63.24%	64.49%	64.97%
Earnings before Interest and Taxes (EBIT)	1,514	1,305	1,103	806	638	546	364	383	330	282
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,916	1,635	1,405	1,074	909	810	573	573	537	493
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.78	11.61	8.11	9.60	6.61	5.00	3.82	3.97	2.81	2.49
Price to Tangible Book Value (P/TBV)	14.76	27.87	34.76	35.28	25.20	32.26	0.00	41.29	21.88	26.06
Price to Revenue (P/Rev)	12.88	13.43	9.69	12.09	8.81	6.07	4.26	4.77	3.71	3.48
Price to Earnings (P/E)	34.86	58.05	45.43	67.08	48.85	38.32	30.76	95.19	33.64	34.50
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.87%	1.72%	2.20%	1.49%	2.05%	2.61%	3.25%	1.05%	2.97%	2.90%
Enterprise Value to Invested Capital (EV/IC)	15.01	17.85	10.77	12.92	8.24	5.67	4.04	5.09	3.53	2.96
Enterprise Value to Revenue (EV/Rev)	12.22	13.14	9.37	11.73	8.51	5.90	4.18	4.44	3.33	3.14
Enterprise Value to EBITDA (EV/EBITDA)	39.09	42.74	30.77	45.94	34.48	24.47	22.79	21.13	15.03	14.26
Enterprise Value to EBIT (EV/EBIT)	49.47	53.52	39.18	61.25	49.13	36.33	35.91	31.58	24.47	24.98
Enterprise Value to NOPAT (EV/NOPAT)	59.14	58.94	43.08	71.50	48.63	39.03	30.46	97.66	31.38	32.90
Enterprise Value to Operating Cash Flow (EV/OCF)	53.23	41.02	24.86	33.05	31.63	24.75	30.76	19.13	13.75	14.21
Enterprise Value to Free Cash Flow (EV/FCFF)	392.40	54.29	53.55	72.94	92.74	82.25	0.00	385.67	23.16	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.02	0.03	0.03	0.13	0.04	0.06	0.07
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.02	0.03	0.04	0.04	0.00	0.00
Financial Leverage	-0.41	-0.33	-0.28	-0.25	-0.19	-0.11	-0.17	-0.28	-0.26	-0.27
Leverage Ratio	1.54	1.68	1.67	1.64	1.60	1.66	1.71	1.64	1.63	1.59
Compound Leverage Factor	1.54	1.68	1.67	1.64	1.60	1.66	1.71	1.64	1.63	1.59
Debt to Total Capital	0.17%	0.29%	0.37%	1.85%	2.54%	3.26%	11.87%	4.21%	6.03%	6.14%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	1.39%	0.54%	0.42%	8.69%	0.29%	6.03%	6.14%
Long-Term Debt to Total Capital	0.17%	0.29%	0.37%	0.46%	2.00%	2.84%	3.17%	3.92%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.36%	0.60%	0.78%	0.07%	0.10%	0.14%	0.15%	0.12%	0.00%	0.00%
Common Equity to Total Capital	99.47%	99.11%	98.85%	98.08%	97.36%	96.60%	87.98%	95.67%	93.97%	93.86%
Debt to EBITDA	0.01	0.01	0.01	0.09	0.14	0.17	0.82	0.25	0.38	0.42
Net Debt to EBITDA	-2.11	-0.96	-1.10	-1.38	-1.22	-0.73	-0.44	-1.58	-1.70	-1.54
Long-Term Debt to EBITDA	0.01	0.01	0.01	0.02	0.11	0.15	0.22	0.23	0.00	0.00
Debt to NOPAT	0.01	0.02	0.02	0.15	0.20	0.27	1.10	1.16	0.80	0.96
Net Debt to NOPAT	-3.19	-1.32	-1.54	-2.15	-1.72	-1.16	-0.59	-7.30	-3.55	-3.55
Long-Term Debt to NOPAT	0.01	0.02	0.02	0.04	0.16	0.24	0.29	1.08	0.00	0.00
Altman Z-Score	13.85	12.22	8.69	10.39	7.69	6.78	4.17	5.00	3.82	3.53
Noncontrolling Interest Sharing Ratio	0.46%	0.69%	0.44%	0.09%	0.12%	0.15%	0.15%	0.06%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.44	1.15	1.09	1.16	1.19	0.99	0.73	1.04	1.00	0.93
Quick Ratio	1.88	0.82	0.85	0.89	0.94	0.73	0.61	0.93	0.91	0.86
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	191	1,287	807	676	338	241	-427	31	348	-15
Operating Cash Flow to CapEx	1,142.43%	887.95%	1,250.27%	1,559.04%	624.40%	395.53%	423.28%	859.89%	825.78%	546.25%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.52	0.54	0.51	0.50	0.51	0.54	0.54	0.51	0.47	0.46
Accounts Receivable Turnover	6.84	6.44	6.77	6.23	5.52	6.07	6.21	6.12	5.88	6.29
Inventory Turnover	3.62	3.84	4.07	4.09	4.76	5.71	7.99	0.00	0.00	0.00
Fixed Asset Turnover	11.01	10.29	9.66	8.79	8.07	9.10	10.85	10.42	9.32	8.76
Accounts Payable Turnover	1.12	1.10	1.16	1.26	1.41	1.39	1.37	1.45	1.38	1.33
Days Sales Outstanding (DSO)	53.35	56.72	53.95	58.57	66.09	60.18	58.79	59.61	62.12	57.99
Days Inventory Outstanding (DIO)	100.75	95.16	89.61	89.23	76.67	63.97	45.70	0.00	0.00	0.00
Days Payable Outstanding (DPO)	325.86	330.94	315.12	289.04	259.53	262.93	267.38	251.44	264.52	275.25
Cash Conversion Cycle (CCC)	-171.77	-179.06	-171.55	-141.24	-116.77	-138.79	-162.89	-191.83	-202.41	-217.27
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,988	3,913	4,014	3,818	3,805	3,498	3,231	2,375	2,283	2,374
Invested Capital Turnover	1.38	1.34	1.18	1.10	1.01	1.00	1.11	1.17	1.04	0.99
Increase / (Decrease) in Invested Capital	1,076	-102	196	14	307	267	856	93	-91	229
Enterprise Value (EV)	74,895	69,864	43,233	49,334	31,353	19,816	13,055	12,099	8,064	7,034
Market Capitalization	78,898	71,394	44,734	50,811	32,456	20,401	13,303	12,999	8,976	7,794
Book Value per Share	$58.53	$40.42	$36.07	$34.72	$32.34	$27.17	$23.41	$21.80	$21.11	$20.10
Tangible Book Value per Share	$34.81	$16.84	$8.42	$9.44	$8.49	$4.21	($0.16)	$2.10	$2.71	$1.92
Total Capital	9,039	6,202	5,580	5,399	5,040	4,227	3,954	3,424	3,400	3,339
Total Debt	16	18	21	100	128	138	469	144	205	205
Total Long-Term Debt	16	18	21	25	101	120	126	134	0.00	0.00
Net Debt	-4,035	-1,568	-1,545	-1,481	-1,108	-591	-254	-904	-912	-760
Capital Expenditures (CapEx)	123	192	139	96	159	202	100	74	71	91
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-231	-1,140	-1,327	-1,111	-799	-725	-938	-970	-910	-869
Debt-free Net Working Capital (DFNWC)	3,820	445	238	470	436	4.08	-215	78	207	95
Net Working Capital (NWC)	3,820	445	238	395	409	-14	-559	68	1.99	-110
Net Nonoperating Expense (NNE)	-969	-33	25	-66	-19	-25	-3.95	-13	-9.84	-12
Net Nonoperating Obligations (NNO)	-4,035	-2,271	-1,545	-1,481	-1,108	-591	-254	-904	-912	-760
Total Depreciation and Amortization (D&A)	402	329	301	268	271	264	209	189	207	212
Debt-free, Cash-free Net Working Capital to Revenue	-3.77%	-21.44%	-28.76%	-26.42%	-21.69%	-21.56%	-30.05%	-35.60%	-37.58%	-38.78%
Debt-free Net Working Capital to Revenue	62.34%	8.37%	5.16%	11.18%	11.84%	0.12%	-6.88%	2.88%	8.54%	4.26%
Net Working Capital to Revenue	62.34%	8.37%	5.16%	9.39%	11.11%	-0.40%	-17.90%	2.51%	0.08%	-4.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$14.78	$8.08	$6.44	$4.96	$4.40	$3.55	$2.90	$0.91	$1.76	$1.46
Adjusted Weighted Average Basic Shares Outstanding	153.14M	152.15M	153.00M	152.70M	151.14M	149.87M	149.04M	150.46M	152.02M	154.96M
Adjusted Diluted Earnings per Share	$14.51	$7.92	$6.29	$4.81	$4.27	$3.45	$2.82	$0.88	$1.73	$1.43
Adjusted Weighted Average Diluted Shares Outstanding	155.94M	155.20M	156.49M	157.34M	155.71M	154.19M	153.39M	154.87M	154.72M	158.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	154.58M	151.99M	152.42M	153.44M	153.03M	150.53M	149.52M	148.71M	150.10M	151.45M
Normalized Net Operating Profit after Tax (NOPAT)	1,266	1,235	1,013	721	459	554	261	269	265	226
Normalized NOPAT Margin	20.67%	23.22%	21.96%	17.16%	12.46%	16.48%	8.37%	9.87%	10.93%	10.07%
Pre Tax Income Margin	24.71%	24.55%	23.91%	19.16%	17.32%	16.23%	11.65%	14.06%	13.60%	12.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	98.98%	112.42%	104.19%	36.49%	61.83%	92.48%	292.91%	149.91%	123.93%

This table displays calculated financial ratios and metrics derived from Synopsys' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.68%	11.81%	12.65%	15.20%	10.99%	63.67%	8.55%	-1.29%	7.17%	-28.98%	18.03%
EBITDA Growth	-32.97%	-6.06%	16.56%	13.49%	51.97%	77.28%	30.83%	-7.59%	-12.40%	3.03%	11.71%
EBIT Growth	-36.36%	-21.99%	20.41%	15.15%	63.83%	101.98%	37.74%	-12.71%	-14.67%	0.50%	10.79%
NOPAT Growth	-23.19%	-33.13%	26.74%	7.12%	36.04%	156.61%	40.98%	-14.56%	-25.90%	-27.22%	15.77%
Net Income Growth	-33.35%	216.20%	21.57%	7.09%	66.11%	128.62%	51.63%	-8.15%	-14.27%	-24.65%	10.71%
EPS Growth	-34.60%	218.30%	20.28%	6.82%	65.14%	128.57%	51.75%	-6.88%	-12.06%	-22.83%	12.60%
Operating Cash Flow Growth	23.16%	72.61%	-18.61%	-32.20%	-176.50%	-17.14%	27.25%	-6.27%	-26.32%	6.19%	4.25%
Free Cash Flow Firm Growth	127.54%	-281.35%	-287.77%	-2,437.24%	-8,224.84%	917.75%	237.65%	-109.71%	-104.88%	-131.54%	-239.42%
Invested Capital Growth	1.09%	27.49%	21.20%	15.69%	23.94%	-2.53%	0.99%	7.24%	6.15%	5.14%	10.99%
Revenue Q/Q Growth	-2.83%	-1.84%	4.88%	-11.79%	12.80%	-1.10%	7.26%	-7.24%	6.00%	-34.41%	-2.46%
EBITDA Q/Q Growth	-21.63%	-3.52%	11.91%	-21.89%	9.84%	19.70%	8.97%	6.07%	22.79%	-11.66%	-23.03%
EBIT Q/Q Growth	-7.65%	-19.58%	14.78%	-26.57%	13.20%	24.12%	9.77%	6.22%	31.63%	-15.35%	-30.44%
NOPAT Q/Q Growth	7.15%	-38.19%	34.92%	-16.55%	-6.71%	17.15%	14.03%	9.16%	58.54%	-35.64%	-30.89%
Net Income Q/Q Growth	-72.85%	170.59%	40.06%	-35.21%	28.78%	4.04%	23.38%	0.49%	77.24%	-31.00%	-25.26%
EPS Q/Q Growth	-73.49%	173.18%	38.83%	-34.95%	29.02%	3.23%	23.30%	0.57%	78.57%	-31.47%	-24.34%
Operating Cash Flow Q/Q Growth	-111.99%	23.58%	-4.44%	642.88%	-126.92%	-41.73%	-20.40%	512.58%	-70.84%	-10.50%	-41.37%
Free Cash Flow Firm Q/Q Growth	123.66%	-67.60%	-34.41%	47.60%	-255.81%	73.53%	1,916.17%	-69.53%	78.94%	70.79%	-228.12%
Invested Capital Q/Q Growth	10.45%	-1.62%	4.41%	-10.89%	39.29%	-6.47%	-0.34%	-4.54%	9.54%	-3.09%	5.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	81.45%	78.30%	80.95%	79.35%	81.52%	82.25%	80.77%	80.34%	79.11%	85.70%	78.27%
EBITDA Margin	24.87%	30.84%	31.38%	29.41%	35.74%	36.71%	30.33%	29.85%	26.10%	33.89%	25.16%
Operating Margin	17.30%	20.28%	23.61%	22.83%	23.34%	31.72%	22.16%	23.15%	18.80%	24.93%	18.75%
EBIT Margin	20.00%	21.05%	25.69%	23.48%	30.28%	30.17%	24.04%	23.49%	20.51%	24.44%	18.94%
Profit (Net Income) Margin	20.44%	73.15%	26.54%	19.87%	29.53%	25.87%	24.59%	21.38%	19.73%	18.52%	17.60%
Tax Burden Percent	102.16%	347.56%	103.29%	84.65%	97.54%	85.75%	102.30%	91.02%	96.20%	75.75%	92.93%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	-2.16%	20.97%	-7.83%	13.30%	5.01%	15.49%	-2.14%	8.07%	3.80%	31.43%	7.07%
Return on Invested Capital (ROIC)	19.59%	22.07%	35.73%	27.64%	24.62%	35.96%	28.61%	27.06%	21.91%	20.15%	21.90%
ROIC Less NNEP Spread (ROIC-NNEP)	18.00%	-5.06%	35.00%	27.58%	15.85%	36.62%	27.01%	26.99%	20.14%	19.38%	21.75%
Return on Net Nonoperating Assets (RNNOA)	-5.68%	2.10%	-11.44%	-8.46%	-3.25%	-11.90%	-7.71%	-7.92%	-4.60%	-5.40%	-5.90%
Return on Equity (ROE)	13.91%	24.17%	24.29%	19.18%	21.37%	24.06%	20.90%	19.13%	17.31%	14.75%	16.00%
Cash Return on Invested Capital (CROIC)	20.61%	4.29%	10.88%	14.34%	4.52%	32.47%	22.59%	14.97%	15.97%	20.62%	16.46%
Operating Return on Assets (OROA)	10.29%	11.02%	15.47%	14.27%	16.45%	16.24%	13.14%	12.75%	11.49%	12.42%	10.53%
Return on Assets (ROA)	10.52%	38.30%	15.98%	12.08%	16.05%	13.93%	13.44%	11.60%	11.05%	9.41%	9.78%
Return on Common Equity (ROCE)	13.88%	24.06%	24.16%	19.06%	21.24%	23.90%	20.74%	18.99%	17.24%	14.68%	15.92%
Return on Equity Simple (ROE_SIMPLE)	22.43%	0.00%	19.28%	19.78%	20.92%	0.00%	17.17%	15.60%	16.56%	0.00%	18.34%
Net Operating Profit after Tax (NOPAT)	257	240	388	288	335	359	306	269	246	140	217
NOPAT Margin	17.68%	16.03%	25.46%	19.79%	22.17%	26.80%	22.63%	21.28%	18.09%	17.10%	17.42%
Net Nonoperating Expense Percent (NNEP)	1.59%	27.13%	0.73%	0.06%	8.77%	-0.66%	1.60%	0.07%	1.77%	0.77%	0.15%
Return On Investment Capital (ROIC_SIMPLE)	2.76%	2.67%	-	-	5.01%	5.82%	-	-	-	2.53%	-
Cost of Revenue to Revenue	18.55%	21.70%	19.05%	20.65%	18.48%	17.75%	19.23%	19.66%	20.89%	14.30%	21.73%
SG&A Expenses to Revenue	11.48%	11.01%	9.86%	7.89%	8.69%	7.08%	7.36%	6.71%	7.15%	8.20%	7.33%
R&D to Revenue	38.01%	35.27%	33.35%	33.90%	34.78%	32.82%	35.77%	36.47%	34.18%	45.34%	35.65%
Operating Expenses to Revenue	64.14%	58.01%	57.34%	56.52%	58.19%	50.53%	58.62%	57.19%	60.31%	60.77%	59.52%
Earnings before Interest and Taxes (EBIT)	291	315	392	342	457	404	326	297	279	200	236
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	362	462	479	428	540	492	411	377	355	277	314
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.73	8.78	11.10	11.32	12.16	11.61	11.54	9.70	9.57	8.11	10.03
Price to Tangible Book Value (P/TBV)	14.27	14.76	21.39	23.47	37.52	27.87	39.65	35.65	38.22	34.76	41.81
Price to Revenue (P/Rev)	13.38	12.88	13.17	12.80	14.84	13.43	13.06	10.97	10.42	9.69	11.36
Price to Earnings (P/E)	38.50	34.86	57.09	56.73	57.63	58.05	66.47	61.43	57.21	45.43	54.44
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.60%	2.87%	1.75%	1.76%	1.74%	1.72%	1.50%	1.63%	1.75%	2.20%	1.84%
Enterprise Value to Invested Capital (EV/IC)	14.05	15.01	16.49	16.34	14.66	17.85	16.01	13.08	11.98	10.77	13.22
Enterprise Value to Revenue (EV/Rev)	12.75	12.22	12.87	12.55	14.61	13.14	12.73	10.65	10.18	9.37	11.06
Enterprise Value to EBITDA (EV/EBITDA)	44.55	39.09	43.04	42.33	43.91	42.74	46.75	41.12	38.55	30.77	39.20
Enterprise Value to EBIT (EV/EBIT)	57.46	49.47	52.28	51.76	53.85	53.52	60.14	53.62	49.35	39.18	49.67
Enterprise Value to NOPAT (EV/NOPAT)	65.11	59.14	60.14	60.65	62.65	58.94	68.24	61.67	56.24	43.08	51.74
Enterprise Value to Operating Cash Flow (EV/OCF)	54.25	53.23	71.44	62.25	53.24	41.02	37.82	33.27	31.03	24.86	31.91
Enterprise Value to Free Cash Flow (EV/FCFF)	68.55	392.40	166.11	122.18	358.98	54.29	71.22	90.46	77.25	53.55	84.49
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.32	-0.41	-0.33	-0.31	-0.20	-0.33	-0.29	-0.29	-0.23	-0.28	-0.27
Leverage Ratio	1.47	1.54	1.57	1.59	1.62	1.68	1.65	1.65	1.67	1.67	1.65
Compound Leverage Factor	1.47	1.54	1.57	1.59	1.62	1.68	1.65	1.65	1.67	1.67	1.65
Debt to Total Capital	0.15%	0.17%	0.20%	0.24%	0.25%	0.29%	0.30%	0.34%	0.36%	0.37%	0.39%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.15%	0.17%	0.20%	0.24%	0.25%	0.29%	0.30%	0.34%	0.36%	0.37%	0.39%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.36%	0.46%	0.50%	0.53%	0.60%	0.69%	0.70%	0.74%	0.78%	0.84%
Common Equity to Total Capital	99.85%	99.47%	99.33%	99.27%	99.22%	99.11%	99.01%	98.96%	98.90%	98.85%	98.77%
Debt to EBITDA	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.01	0.02
Net Debt to EBITDA	-2.18	-2.11	-1.02	-0.88	-0.69	-0.96	-1.27	-1.25	-0.94	-1.10	-1.08
Long-Term Debt to EBITDA	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.01	0.02
Debt to NOPAT	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.02	0.02
Net Debt to NOPAT	-3.19	-3.19	-1.42	-1.26	-0.99	-1.32	-1.85	-1.88	-1.37	-1.54	-1.43
Long-Term Debt to NOPAT	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.02	0.02
Altman Z-Score	14.94	13.55	15.03	14.56	14.34	11.93	12.12	10.21	9.85	8.37	10.64
Noncontrolling Interest Sharing Ratio	0.22%	0.46%	0.56%	0.59%	0.63%	0.69%	0.76%	0.76%	0.41%	0.44%	0.48%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.68	2.44	2.02	1.86	1.29	1.15	1.20	1.15	1.11	1.09	1.14
Quick Ratio	1.99	1.88	1.10	0.99	0.88	0.82	0.92	0.90	0.86	0.85	0.87
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	198	-835	-498	-371	-718	461	265	-15	-8.62	-56	-193
Operating Cash Flow to CapEx	-165.68%	12,823.38%	1,138.27%	1,242.03%	-217.35%	614.07%	1,213.48%	1,449.63%	260.06%	1,088.59%	1,236.24%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.51	0.52	0.60	0.61	0.54	0.54	0.55	0.54	0.56	0.51	0.56
Accounts Receivable Turnover	6.21	6.84	8.82	7.83	5.21	6.44	7.80	6.86	4.99	6.77	7.85
Inventory Turnover	3.10	3.62	4.04	4.16	3.40	3.84	4.28	4.62	5.03	4.07	4.41
Fixed Asset Turnover	10.91	11.01	11.73	11.36	10.09	10.29	10.29	9.93	10.40	9.66	10.34
Accounts Payable Turnover	1.51	1.12	1.62	1.97	1.51	1.10	1.31	1.65	1.81	1.16	1.50
Days Sales Outstanding (DSO)	58.82	53.35	41.36	46.61	70.08	56.72	46.79	53.19	73.18	53.95	46.48
Days Inventory Outstanding (DIO)	117.81	100.75	90.45	87.75	107.40	95.16	85.25	78.94	72.56	89.61	82.80
Days Payable Outstanding (DPO)	241.87	325.86	224.84	185.07	242.53	330.94	278.49	220.72	201.44	315.12	242.90
Cash Conversion Cycle (CCC)	-65.24	-171.77	-93.02	-50.70	-65.06	-179.06	-146.45	-88.59	-55.71	-171.55	-113.62
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,510	4,988	5,070	4,856	5,450	3,913	4,183	4,198	4,397	4,014	4,142
Invested Capital Turnover	1.11	1.38	1.40	1.40	1.11	1.34	1.26	1.27	1.21	1.18	1.26
Increase / (Decrease) in Invested Capital	60	1,076	887	659	1,053	-102	41	283	255	196	410
Enterprise Value (EV)	77,433	74,895	83,601	79,331	79,893	69,864	66,971	54,918	52,678	43,233	54,755
Market Capitalization	81,228	78,898	85,544	80,938	81,114	71,394	68,746	56,553	53,918	44,734	56,217
Book Value per Share	$60.19	$58.53	$50.32	$46.89	$43.80	$40.42	$39.16	$38.29	$36.98	$36.07	$36.63
Tangible Book Value per Share	$36.81	$34.81	$26.10	$22.61	$14.20	$16.84	$11.40	$10.42	$9.26	$8.42	$8.79
Total Capital	9,319	9,039	7,761	7,206	6,724	6,202	6,018	5,893	5,699	5,580	5,674
Total Debt	14	16	16	17	17	18	18	20	21	21	22
Total Long-Term Debt	14	16	16	17	17	18	18	20	21	21	22
Net Debt	-3,795	-4,035	-1,979	-1,643	-1,256	-1,568	-1,816	-1,675	-1,281	-1,545	-1,509
Capital Expenditures (CapEx)	41	4.39	40	38	40	53	46	48	44	36	36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	156	-231	599	485	-510	-1,140	-1,296	-1,283	-999	-1,327	-1,178
Debt-free Net Working Capital (DFNWC)	3,965	3,820	2,593	2,145	763	445	538	412	303	238	353
Net Working Capital (NWC)	3,965	3,820	2,593	2,145	763	445	538	412	303	238	353
Net Nonoperating Expense (NNE)	-40	-856	-16	-1.20	-111	13	-27	-1.18	-22	-12	-2.25
Net Nonoperating Obligations (NNO)	-3,795	-4,035	-2,675	-2,332	-1,256	-2,271	-1,816	-1,675	-1,281	-1,545	-1,509
Total Depreciation and Amortization (D&A)	71	147	87	86	83	88	85	80	76	77	78
Debt-free, Cash-free Net Working Capital to Revenue	2.56%	-3.77%	9.22%	7.67%	-9.33%	-21.44%	-24.63%	-24.89%	-19.30%	-28.76%	-23.80%
Debt-free Net Working Capital to Revenue	65.30%	62.34%	39.93%	33.92%	13.96%	8.37%	10.23%	8.00%	5.87%	5.16%	7.14%
Net Working Capital to Revenue	65.30%	62.34%	39.93%	33.92%	13.96%	8.37%	10.23%	8.00%	5.87%	5.16%	7.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.91	$7.26	$2.66	$1.91	$2.95	$2.30	$2.21	$1.79	$1.78	$1.00	$1.46
Adjusted Weighted Average Basic Shares Outstanding	154.41M	153.14M	153.42M	152.97M	152.31M	152.15M	152.02M	152.19M	152.40M	153.00M	152.94M
Adjusted Diluted Earnings per Share	$1.89	$7.13	$2.61	$1.88	$2.89	$2.24	$2.17	$1.76	$1.75	$0.98	$1.43
Adjusted Weighted Average Diluted Shares Outstanding	156.19M	155.94M	156.13M	155.77M	155.33M	155.20M	154.95M	154.73M	155.08M	156.49M	155.81M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	154.62M	154.58M	153.61M	153.22M	152.54M	151.99M	304.17M	304.32M	152.30M	152.42M	152.91M
Normalized Net Operating Profit after Tax (NOPAT)	176	240	252	288	335	356	225	264	286	139	217
Normalized NOPAT Margin	12.11%	16.03%	16.53%	19.79%	22.17%	26.55%	16.64%	20.88%	20.97%	17.03%	17.42%
Pre Tax Income Margin	20.00%	21.05%	25.69%	23.48%	30.28%	30.17%	24.04%	23.49%	20.51%	24.44%	18.94%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	20.18%	42.41%	0.00%	98.98%	122.02%	132.53%	123.78%	112.42%	94.58%

Frequently Asked Questions About Synopsys' Financials

When does Synopsys's fiscal year end?

According to the most recent income statement we have on file, Synopsys' financial year ends in October. Their financial year 2024 ended on October 31, 2024.

How has Synopsys' net income changed over the last 9 years?

Synopsys' net income appears to be on an upward trend, with a most recent value of $2.24 billion in 2024, rising from $225.93 million in 2015. The previous period was $1.22 billion in 2023. View Synopsys' forecast to see where analysts expect Synopsys to go next.

What is Synopsys's operating income?

Synopsys's total operating income in 2024 was $1.36 billion, based on the following breakdown:

Total Gross Profit: $4.88 billion
Total Operating Expenses: $3.53 billion

How has Synopsys revenue changed over the last 9 years?

Over the last 9 years, Synopsys' total revenue changed from $2.24 billion in 2015 to $6.13 billion in 2024, a change of 173.3%.

How much debt does Synopsys have?

Synopsys' total liabilities were at $4.05 billion at the end of 2024, a 2.4% decrease from 2023, and a 111.9% increase since 2015.

How much cash does Synopsys have?

In the past 9 years, Synopsys' cash and equivalents has ranged from $723.12 million in 2018 to $3.90 billion in 2024, and is currently $3.90 billion as of their latest financial filing in 2024.

How has Synopsys' book value per share changed over the last 9 years?

Over the last 9 years, Synopsys' book value per share changed from 20.10 in 2015 to 58.53 in 2024, a change of 191.2%.

Related Companies

This page (NASDAQ:SNPS) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synopsys (SNPS) Financials

Frequently Asked Questions About Synopsys' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synopsys (SNPS) Financials

Annual Income Statements for Synopsys

Quarterly Income Statements for Synopsys

Annual Cash Flow Statements for Synopsys

Quarterly Cash Flow Statements for Synopsys

Annual Balance Sheets for Synopsys

Quarterly Balance Sheets for Synopsys

Annual Metrics And Ratios for Synopsys

Quarterly Metrics And Ratios for Synopsys

Frequently Asked Questions About Synopsys' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools